NUCLEAR MEDICINE COMMUNICATIONS, cilt.36, ss.1195-1201, 2015 (SCI İndekslerine Giren Dergi)
Introduction F-18-Fluorodeoxyglucose (F-18-FDG) PET/CT represents an imaging modality that is gaining increasingly more prominence in screening, staging, and therapeutic monitoring of malignant diseases. An incidental focus of uptake in different regions of the body is not an uncommon finding during PET/CT imaging. Patients with incidental gastrointestinal tract findings comprise approximate to 3% of the overall patient group. The aim of the current study was to provide contributory information in relation to the answer on the most appropriate approach in cases with incidental colonic F-18-FDG uptake.